BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

373 related articles for article (PubMed ID: 29671158)

  • 21. The changing epidemiology of esophageal cancer in Finland and the impact of the surveillance of Barrett's esophagus in detecting esophageal adenocarcinoma.
    Voutilainen ME; Juhola MT
    Dis Esophagus; 2005; 18(4):221-5. PubMed ID: 16128777
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Risk factors in the development of esophageal adenocarcinoma.
    Pohl H; Wrobel K; Bojarski C; Voderholzer W; Sonnenberg A; Rösch T; Baumgart DC
    Am J Gastroenterol; 2013 Feb; 108(2):200-7. PubMed ID: 23247577
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Interactions Between Genetic Variants and Environmental Factors Affect Risk of Esophageal Adenocarcinoma and Barrett's Esophagus.
    Dong J; Levine DM; Buas MF; Zhang R; Onstad L; Fitzgerald RC; ; Corley DA; Shaheen NJ; Lagergren J; Hardie LJ; Reid BJ; Iyer PG; Risch HA; Caldas C; Caldas I; Pharoah PD; Liu G; Gammon MD; Chow WH; Bernstein L; Bird NC; Ye W; Wu AH; Anderson LA; MacGregor S; Whiteman DC; Vaughan TL; Thrift AP
    Clin Gastroenterol Hepatol; 2018 Oct; 16(10):1598-1606.e4. PubMed ID: 29551738
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Helicobacter pylori eradication treatment and the risk of Barrett's esophagus and esophageal adenocarcinoma.
    Doorakkers E; Lagergren J; Santoni G; Engstrand L; Brusselaers N
    Helicobacter; 2020 Jun; 25(3):e12688. PubMed ID: 32175626
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Adenocarcinoma of the esophagus and Barrett's esophagus: a population-based study.
    Bytzer P; Christensen PB; Damkier P; Vinding K; Seersholm N
    Am J Gastroenterol; 1999 Jan; 94(1):86-91. PubMed ID: 9934736
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Adenocarcinoma and Barrett's esophagus. An overrated risk?
    Spechler SJ; Robbins AH; Rubins HB; Vincent ME; Heeren T; Doos WG; Colton T; Schimmel EM
    Gastroenterology; 1984 Oct; 87(4):927-33. PubMed ID: 6468881
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Risk factors, DNA damage, and disease progression in Barrett's esophagus.
    Olliver JR; Hardie LJ; Gong Y; Dexter S; Chalmers D; Harris KM; Wild CP
    Cancer Epidemiol Biomarkers Prev; 2005 Mar; 14(3):620-5. PubMed ID: 15767340
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Barrett's esophagus. Prevalence, risk of adenocarcinoma, role of endoscopic surveillance].
    Zaninotto G; Costantini M; Molena D; Rizzetto C; Ekser B; Ancona E
    Minerva Chir; 2002 Dec; 57(6):819-36. PubMed ID: 12592224
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Management of Barrett's esophagus: cases and questions.
    Bresalier R
    Semin Oncol; 2005 Dec; 32(6 Suppl 9):S2-5. PubMed ID: 16399421
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The incidence of adenocarcinoma in columnar-lined (Barrett's) esophagus.
    Cameron AJ; Ott BJ; Payne WS
    N Engl J Med; 1985 Oct; 313(14):857-9. PubMed ID: 4033716
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Barrett's esophagus and adenocarcinoma.
    Reid BJ; Weinstein WM
    Annu Rev Med; 1987; 38():477-92. PubMed ID: 3555308
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The pathogenesis of Barrett's metaplasia and the progression to esophageal adenocarcinoma.
    Grotenhuis BA; van Lanschot JJ; Dinjens WN; Wijnhoven BP
    Recent Results Cancer Res; 2010; 182():39-63. PubMed ID: 20676870
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Trends in incidence and prevalence of specialized intestinal metaplasia, barrett's esophagus, and adenocarcinoma of the gastroesophageal junction.
    Pera M
    World J Surg; 2003 Sep; 27(9):999-1008; discussion 1006-8. PubMed ID: 12917764
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Hiatal hernia size, Barrett's length, and severity of acid reflux are all risk factors for esophageal adenocarcinoma.
    Avidan B; Sonnenberg A; Schnell TG; Chejfec G; Metz A; Sontag SJ
    Am J Gastroenterol; 2002 Aug; 97(8):1930-6. PubMed ID: 12190156
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Esophagitis: incidence and risk of esophageal adenocarcinoma--a population-based cohort study.
    Lassen A; Hallas J; de Muckadell OB
    Am J Gastroenterol; 2006 Jun; 101(6):1193-9. PubMed ID: 16771936
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Barrett's esophagus.
    Phillips WA; Lord RV; Nancarrow DJ; Watson DI; Whiteman DC
    J Gastroenterol Hepatol; 2011 Apr; 26(4):639-48. PubMed ID: 21166712
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Bacterial Composition of the Human Upper Gastrointestinal Tract Microbiome Is Dynamic and Associated with Genomic Instability in a Barrett's Esophagus Cohort.
    Gall A; Fero J; McCoy C; Claywell BC; Sanchez CA; Blount PL; Li X; Vaughan TL; Matsen FA; Reid BJ; Salama NR
    PLoS One; 2015; 10(6):e0129055. PubMed ID: 26076489
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Risk factors for esophageal cancer development.
    Falk GW
    Surg Oncol Clin N Am; 2009 Jul; 18(3):469-85. PubMed ID: 19500737
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Epidemiology and significance of Barrett's esophagus.
    DeVault KR
    Dig Dis; 2000-2001; 18(4):195-202. PubMed ID: 11356990
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Adenocarcinoma in Barrett's esophagus after elimination of gastroesophageal reflux.
    Hamilton SR; Hutcheon DF; Ravich WJ; Cameron JL; Paulson M
    Gastroenterology; 1984 Feb; 86(2):356-60. PubMed ID: 6690363
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 19.